Screener
Merck & Co. MRK Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiGainLoss.
The source filing: Merck & Co.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:11 PM EDT
- Fiscal quarter
- Q3 FY2028
- Calendar quarter
- Q3 2028
- Accession
- 0000310158-26-000212
| ($ in millions) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest income | $(35) | $(69) | $(70) | $(178) |
| Interest expense | 525 | 305 | 1,004 | 618 |
| Exchange losses | 37 | 78 | 75 | 167 |
| Income from investments in equity securities, net (1) | (242) | (100) | (411) | (189) |
| Net periodic defined benefit plan (credit) cost other than service cost | (127) | (152) | (262) | (300) |
| Other, net | (59) | (69) | (99) | (161) |
| $99 | $(7) | $237 | $(43) |
Item 1. Financial Statements
FAQ
- What is Merck & Co.'s net gains (losses) on investments?
- Merck & Co. (MRK) reported net gains (losses) on investments of $242M in Q2 2026.
- How has Merck & Co.'s net gains (losses) on investments changed year-over-year?
- Merck & Co.'s net gains (losses) on investments increased by 142.0% year-over-year, from $100M to $242M.
- What is the long-term trend for Merck & Co.'s net gains (losses) on investments?
- Over 2 years (2021 to 2023), Merck & Co.'s net gains (losses) on investments has grown at a -58.0% compound annual growth rate (CAGR), from $1.94B to $342M.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.
Ask your AI about Merck & Co.'s net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude